T1	Participants 51 107	rectal cancer patients with high preoperative CEA levels
T2	Participants 245 286	postoperative CEA levels in rectal cancer
T3	Participants 347 378	122 patients with rectal cancer
T4	Participants 473 535	Patients with preoperative CEA levels <5.0 ng/ml were excluded
T5	Participants 1282 1320	patients with stage III rectal cancer.
T6	Participants 1325 1357	those with stage II rectal cance
T7	Participants 1586 1613	patients with rectal cancer
T8	Participants 1615 1665	Patients with a randomized pattern of CEA clearanc
